The data is clear: for patients with early stage breast cancer, certain operations risk more harm than good -- increasing the risk of medical complications, missed work and health care costs without increasing survival rates.
A $1.4 million grant from the American Cancer Society will allow a team of researchers led by the University of Michigan Rogel Cancer Center to survey a diverse group of breast cancer patients and their relatives about their experience with genetic testing and their understanding of hereditary cancer risk and prevention.
Women with early stage breast cancer who test positive for an inherited genetic variant aren’t always receiving cancer treatment that follows current guidelines, a new study finds.
A U-M Rogel Cancer Center study found aggressive breast cancer cells stored high amounts of energy which enabled them to spread. This suggests a potential target in the metabolism that could slow or prevent breast cancer metastasis.
MENU
